The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia.
作者信息
Matsuo Hidemasa, Goyama Susumu, Kamikubo Yasuhiko, Adachi Souichi
机构信息
Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Japan.
Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, OH, USA.
出版信息
Haematologica. 2015 Mar;100(3):e116-7. doi: 10.3324/haematol.2015.124396.
Abstract
摘要
相似文献
1
The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia.急性髓系白血病中EVI1和PRDM16的亚型特异性特征。
Haematologica. 2015 Mar;100(3):e116-7. doi: 10.3324/haematol.2015.124396.
2
The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features.携带EVI1或PRDM16重排的密切相关的罕见且严重的急性髓系白血病具有独特的生物学特征。
Haematologica. 2015 Mar;100(3):e114-5. doi: 10.3324/haematol.2014.121079.
3
EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia.EVI1过表达是混合谱系白血病-AF9重排急性髓系白血病患儿的不良预后因素。
Haematologica. 2014 Nov;99(11):e225-7. doi: 10.3324/haematol.2014.107128. Epub 2014 Jul 11.
4
Marked thrombocytosis and dysmegakaryopoiesis in acute myeloid leukemia with t(2;3)(p22;q26.2) and EVI1 rearrangement.伴有t(2;3)(p22;q26.2)和EVI1重排的急性髓系白血病中的显著血小板增多和巨核细胞生成异常。
Ann Hematol. 2013 Dec;92(12):1713-5. doi: 10.1007/s00277-013-1750-0. Epub 2013 Apr 19.
5
Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia.嗜异性病毒整合位点-1在急性髓系白血病和急性淋巴细胞白血病中的异常表达。
Leuk Lymphoma. 2015 Feb;56(2):472-9. doi: 10.3109/10428194.2014.924118. Epub 2014 Jun 25.
6
3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review.髓系血液病中3q26/EVI1重排：细胞遗传学综述
Future Oncol. 2015;11(11):1675-86. doi: 10.2217/fon.15.64.
7
Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia.EVI1 的下调与急性髓系白血病患者的表观遗传改变和良好预后相关。
Haematologica. 2011 Oct;96(10):1448-56. doi: 10.3324/haematol.2011.040535. Epub 2011 Jul 12.
8
High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group.EVI1 高表达与 MLL 重排相关，并预示着儿科急性髓系白血病患者生存时间缩短：来自儿童肿瘤协作组的报告。
Br J Haematol. 2013 Sep;162(5):670-7. doi: 10.1111/bjh.12444. Epub 2013 Jul 4.
9
Improved classification of MLL-AF9-positive acute myeloid leukemia patients based on BRE and EVI1 expression.基于BRE和EVI1表达对MLL-AF9阳性急性髓系白血病患者进行改进分类。
Blood. 2012 May 3;119(18):4335-7. doi: 10.1182/blood-2012-02-405019.
10
Dysregulated EVI1 expression in myeloid malignancies.髓系恶性肿瘤中EVI1表达失调
Leuk Lymphoma. 2006 Dec;47(12):2443-4. doi: 10.1080/10428190601040258.
引用本文的文献
1
Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies.组蛋白修饰及其在血液系统恶性肿瘤中的治疗靶点的影响。
Int J Mol Sci. 2022 Nov 7;23(21):13657. doi: 10.3390/ijms232113657.
2
Multifaceted Role of PRDM Proteins in Human Cancer.PRDM 蛋白在人类癌症中的多方面作用。
Int J Mol Sci. 2020 Apr 10;21(7):2648. doi: 10.3390/ijms21072648.
3
MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia.MiR-340是急性髓系白血病中用于选择化疗和异基因移植治疗的生物标志物。
Front Oncol. 2019 Oct 11;9:1058. doi: 10.3389/fonc.2019.01058. eCollection 2019.
4
Detection of genetic alterations in gastric cancer patients from Saudi Arabia using comparative genomic hybridization (CGH).采用比较基因组杂交（CGH）技术检测沙特阿拉伯胃癌患者的基因改变。
PLoS One. 2018 Sep 13;13(9):e0202576. doi: 10.1371/journal.pone.0202576. eCollection 2018.
5
PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature.PRDM16 异构体差异调节正常和白血病造血及炎症基因特征。
J Clin Invest. 2018 Aug 1;128(8):3250-3264. doi: 10.1172/JCI99862. Epub 2018 Jul 23.
6
High EVI1 Expression Predicts Poor Outcomes in Adult Acute Myeloid Leukemia Patients with Intermediate Cytogenetic Risk Receiving Chemotherapy.EVI1 高表达预示着接受化疗的中危核型成人急性髓系白血病患者预后不良。
Med Sci Monit. 2018 Feb 6;24:758-767. doi: 10.12659/msm.905903.
7
Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies.ASXL1 截断蛋白功能获得在髓系恶性肿瘤发病机制中的作用。
Blood. 2018 Jan 18;131(3):328-341. doi: 10.1182/blood-2017-06-789669. Epub 2017 Nov 7.
8
Loss of Asxl2 leads to myeloid malignancies in mice.Asxl2 缺失导致小鼠发生髓系恶性肿瘤。
Nat Commun. 2017 Jun 8;8:15456. doi: 10.1038/ncomms15456.
9
Epigenetics in normal and malignant hematopoiesis: An overview and update 2017.2017年正常及恶性造血中的表观遗传学：综述与更新
Cancer Sci. 2017 Apr;108(4):553-562. doi: 10.1111/cas.13168. Epub 2017 Apr 20.
10
Mapping Whole-Transcriptome Splicing in Mouse Hematopoietic Stem Cells.小鼠造血干细胞全转录组剪接图谱分析
Stem Cell Reports. 2017 Jan 10;8(1):163-176. doi: 10.1016/j.stemcr.2016.12.002. Epub 2016 Dec 29.
本文引用的文献
1
The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features.携带EVI1或PRDM16重排的密切相关的罕见且严重的急性髓系白血病具有独特的生物学特征。
Haematologica. 2015 Mar;100(3):e114-5. doi: 10.3324/haematol.2014.121079.
2
High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML.EVI1 和 MEL1 的高表达是小儿急性髓系白血病不良预后的一个有力标志。
Leukemia. 2015 May;29(5):1076-83. doi: 10.1038/leu.2015.5. Epub 2015 Jan 8.
3
EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia.EVI1过表达是混合谱系白血病-AF9重排急性髓系白血病患儿的不良预后因素。
Haematologica. 2014 Nov;99(11):e225-7. doi: 10.3324/haematol.2014.107128. Epub 2014 Jul 11.
4
An MLL-dependent network sustains hematopoiesis.一个依赖于 MLL 的网络维持着造血。
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12000-5. doi: 10.1073/pnas.1301278110. Epub 2013 Jun 6.
5
HemaExplorer: a database of mRNA expression profiles in normal and malignant haematopoiesis.HemaExplorer：正常和恶性造血中 mRNA 表达谱的数据库。
Nucleic Acids Res. 2013 Jan;41(Database issue):D1034-9. doi: 10.1093/nar/gks1021. Epub 2012 Nov 9.
6
PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.PRDM16（1p36）易位定义了一种预后不良的髓系恶性肿瘤的独特实体，但也可能发生在淋巴恶性肿瘤中。
Br J Haematol. 2012 Jan;156(1):76-88. doi: 10.1111/j.1365-2141.2011.08918.x. Epub 2011 Nov 3.
7
Prdm16 is a physiologic regulator of hematopoietic stem cells.PRDM16 是造血干细胞的生理调节因子。
Blood. 2011 May 12;117(19):5057-66. doi: 10.1182/blood-2010-08-300145. Epub 2011 Feb 22.
8
Evi-1 as a critical regulator of leukemic cells.Evi-1 作为白血病细胞的关键调节因子。
Int J Hematol. 2010 Jun;91(5):753-7. doi: 10.1007/s12185-010-0618-5. Epub 2010 Jun 8.
9
Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells.Evi-1是造血干细胞和转化白血病细胞的关键调节因子。
Cell Stem Cell. 2008 Aug 7;3(2):207-20. doi: 10.1016/j.stem.2008.06.002.
10
Leukemogenesis of the EVI1/MEL1 gene family.EVI1/MEL1基因家族的白血病发生
Int J Hematol. 2007 May;85(4):279-86. doi: 10.1532/IJH97.06174.
Zotero 插件